Huseyin Naci

Citeras av

	Alla	Sedan 2020
Citat	8530	4712
h-index	42	33
i10-index	91	79

960

480

240

720

201020112012201320142015201620172018201920202021202220232024202524 54 101 156 339 376 500 587 721 786 856 944 917 955 900 119

Offentlig åtkomst

Visa alla

45 artiklar

6 artiklar

tillgänglig

inte tillgänglig

Enligt krav från finansiärer

Medförfattare

Elias MossialosLondon School of EconomicsVerifierad e-postadress på lse.ac.uk
Rachael FleurenceNational Institutes of HealthVerifierad e-postadress på nih.gov
Maximilian Salcher-KonradPharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute)Verifierad e-postadress på goeg.at
Aaron KesselheimProfessor of Medicine, Harvard Medical School & Brigham and Women's HospitalVerifierad e-postadress på partners.org
John P.A. IoannidisProfessor of Medicine/Health Research & Policy/Biomedical Data Science/Statistics, Stanford UnivVerifierad e-postadress på stanford.edu
Anita Katharina WagnerAssociate Professor of Population MedicineVerifierad e-postadress på hms.harvard.edu
Georgia SalantiAssociate Professor in Biostatistics and Epidemiology, University of BernVerifierad e-postadress på ispm.unibe.ch
Sofia DiasUniversity of YorkVerifierad e-postadress på york.ac.uk
Dan Chisholmworld Health OrganizationVerifierad e-postadress på who.int
Andrea CiprianiProfessor of Psychiatry and NIHR Research Professor, Department of Psychiatry, University of OxfordVerifierad e-postadress på psych.ox.ac.uk
Prof Julian HigginsUniversity of BristolVerifierad e-postadress på bristol.ac.uk
Emilie CourtinLondon School of Economics and Political ScienceVerifierad e-postadress på lse.ac.uk
Bishal GyawaliQueen's University, Kingston, CanadaVerifierad e-postadress på queensu.ca
Xiaodong GuanPeking UniversityVerifierad e-postadress på pku.edu.cn
David NunanCentre for Evidence Based Medicine, Departmental Lecturer/Senior Researcher, University of OxfordVerifierad e-postadress på phc.ox.ac.uk
Manuel BlumDepartment of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, SwitzerlandVerifierad e-postadress på insel.ch
Aris AngelisSecretary General Ministry of Health | Visiting Associate Professor LSHTM | Visiting Fellow LSEVerifierad e-postadress på lshtm.ac.uk
Jelena SavovicUniversity of Bristol; NIHR ARC West University Hospitals Bristol and Weston NHS Foundation TrustVerifierad e-postadress på bristol.ac.uk
Stephen SoumeraiProfessor, Harvard Medical School, Harvard Pilgrim Health Care InstituteVerifierad e-postadress på hms.harvard.edu
Titus KuehneProfessor der Medizin, Charité - Universitätsmedizin BerlinVerifierad e-postadress på charite.de

Följ

Huseyin Naci

London School of Economics

Verifierad e-postadress på lse.ac.uk - Startsida

Health Policy Pharmaceutical Policy Pharmaceutical Regulation Prescription Drugs


Titel Sortera efter citat Sortera efter år Sortera efter titel	Citeras av Citeras av	År
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study H Naci, JPA Ioannidis Bmj 347, f5577, 2013	1003	2013
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals … C Davis, H Naci, E Gurpinar, E Poplavska, A Pinto, A Aggarwal bmj 359, 2017	690	2017
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers JP Jansen, H Naci BMC medicine 11, 1-8, 2013	591	2013
From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management E Mossialos, E Courtin, H Naci, S Benrimoj, M Bouvy, K Farris, P Noyce, ... Health policy 119 (5), 628-639, 2015	557	2015
Distribution of road traffic deaths by road user group: a global comparison H Naci, D Chisholm, TD Baker Injury prevention 15 (1), 55-59, 2009	464	2009
Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials H Naci, J Brugts, T Ades Circulation: Cardiovascular Quality and Outcomes 6 (4), 390-399, 2013	412	2013
How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on … H Naci, M Salcher-Konrad, S Dias, MR Blum, SA Sahoo, D Nunan, ... British journal of sports medicine 53 (14), 859-869, 2019	363	2019
Economic burden of multiple sclerosis: a systematic review of the literature H Naci, R Fleurence, J Birt, A Duhig Pharmacoeconomics 28, 363-379, 2010	289	2010
Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and … H Naci, JJ Brugts, R Fleurence, B Tsoi, H Toor, AE Ades european Journal of preventive Cardiology 20 (4), 641-657, 2013	250	2013
Characteristics of preapproval and postapproval studies for drugs granted accelerated approval by the US Food and Drug Administration H Naci, KR Smalley, AS Kesselheim Jama 318 (7), 626-636, 2017	205	2017
Evaluation of Wellness Determinants and Interventions by Citizen Scientists H Naci, JPA Ioannidis JAMA 350, h1323, 2015	187	2015
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional … H Naci, C Davis, J Savović, JPT Higgins, JAC Sterne, B Gyawali, ... bmj 366, 2019	141	2019
Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence? E Mossialos, H Naci, E Courtin Health policy 111 (2), 135-148, 2013	135	2013
Prognostic significance of left ventricular noncompaction: systematic review and meta-analysis of observational studies N Aung, S Doimo, F Ricci, MM Sanghvi, C Pedrosa, SP Woodbridge, ... Circulation: Cardiovascular Imaging 13 (1), e009712, 2020	110	2020
Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study D Chisholm, H Naci, AA Hyder, NT Tran, M Peden Bmj 344, 2012	109	2012
How good is “evidence” from clinical studies of drug effects and why might such evidence fail in the prediction of the clinical utility of drugs? H Naci, JPA Ioannidis Annual review of pharmacology and toxicology 55 (1), 169-189, 2015	98	2015
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology N Jackson, D Atar, M Borentain, G Breithardt, M van Eickels, M Endres, ... European heart journal 37 (9), 747-754, 2016	88	2016
The critical role of observational evidence in comparative effectiveness research RL Fleurence, H Naci, JP Jansen Health Affairs 29 (10), 1826-1833, 2010	87	2010
Generating comparative evidence on new drugs and devices before approval H Naci, M Salcher-Konrad, AS Kesselheim, B Wieseler, L Rochaix, ... The Lancet 395 (10228), 986-997, 2020	84	2020
Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials H Naci, JJ Brugts, R Fleurence, AE Ades European journal of preventive cardiology 20 (4), 658-670, 2013	84	2013

Systemet kan inte utföra åtgärden just nu. Försök igen senare.

Artiklar 1–20

Citat per år

Dubblettcitat

Sammanfogade citat

Lägg till medförfattareMedförfattare

Följ

Citeras av

Medförfattare